Ignite Creation Date:
2024-05-05 @ 11:58 PM
Last Modification Date:
2024-10-26 @ 10:42 AM
Study NCT ID:
NCT01451606
Status:
TERMINATED
Last Update Posted:
2019-09-26
First Post:
2011-10-11
Brief Title:
Duloxetine for the Treatment of Chronic Pelvic Pain
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
Evaluating Duloxetines Analgesic Effectiveness in Chronic Pelvic Pain
Status:
TERMINATED
Status Verified Date:
2019-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Adequate recruitment was not achieved in the time frame allowed
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is examining the effectiveness of duloxetine as a treatment for chronic pelvic pain in women Duloxetine is FDA approved for the treatment of other pain conditions including fibromyalgia and diabetic neuropathy
Detailed Description:
Chronic pelvic pain in women can be caused by various pathologies such as endometriosis fibroids and adhesions Surgical treatment of the pathology often relieves the pain but a significant number of women continue to have pain even after visibly successful surgery One model explored in this study is that in some cases of chronic pelvic pain the central nervous system has changed in its processing of pain-related signals requiring a therapy directed to the Central Nervous System CNS to effectively treat the pain This model has been supported in studies of other chronic pain conditions such as fibromyalgia and migraine This study will seek to determine whether the analgesic effectiveness of duloxetine is related to the pain state of the individual
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None